113 related articles for article (PubMed ID: 24922636)
61. ROS1 copy number alterations are frequent in non-small cell lung cancer.
Clavé S; Gimeno J; Muñoz-Mármol AM; Vidal J; Reguart N; Carcereny E; Pijuan L; Menéndez S; Taus Á; Mate JL; Serrano S; Albanell J; Espinet B; Arriola E; Salido M
Oncotarget; 2016 Feb; 7(7):8019-28. PubMed ID: 26783962
[TBL] [Abstract][Full Text] [Related]
62. Genetic Polymorphisms in Activating Transcription Factor 3 Binding Site and the Prognosis of Early-Stage Non-Small Cell Lung Cancer.
Kang HG; Park JE; Lee SY; Choi JE; Do SK; Hong MJ; Lee JH; Jeong JY; Do YW; Lee EB; Shin KM; Lee WK; Choi SH; Lee YH; Seo HW; Yoo SS; Lee J; Cha SI; Kim CH; Cho S; Jheon S; Park JY
Oncology; 2021; 99(5):336-344. PubMed ID: 33626541
[TBL] [Abstract][Full Text] [Related]
63. HSP90B1 overexpression predicts poor prognosis in NSCLC patients.
Xu Y; Chen Z; Zhang G; Xi Y; Sun R; Wang X; Wang W; Chai F; Li X
Tumour Biol; 2016 Oct; 37(10):14321-14328. PubMed ID: 27599983
[TBL] [Abstract][Full Text] [Related]
64. Biomarkers as prognostic factors for cN2 or 3 non-small cell lung cancer treated by induction chemoradiotherapy and surgery.
Yokomise H; Liu D; Chang S; Go T; Ishikawa S; Misaki N; Nakashima N
Anticancer Res; 2013 Mar; 33(3):1107-15. PubMed ID: 23482788
[TBL] [Abstract][Full Text] [Related]
65. Correlation and coexpression of HIFs and NOTCH markers in NSCLC.
Andersen S; Donnem T; Al-Saad S; Al-Shibli K; Stenvold H; Busund LT; Bremnes RM
Anticancer Res; 2011 May; 31(5):1603-6. PubMed ID: 21617216
[TBL] [Abstract][Full Text] [Related]
66. The Utility of Thyroid Transcription Factor 1 (TTF-1), Napsin A, Excision Repair Cross-Complementing 1 (ERCC1), Anaplastic Lymphoma Kinase (ALK) and the Epidermal Growth Factor Receptor (EGFR) Expression in Small Biopsy in Prognosis of Patients with Lung Adenocarcinoma - A Retrograde Single-Center Study from Croatia.
Piljić Burazer M; Mladinov S; Ćapkun V; Kuret S; Glavina Durdov M
Med Sci Monit; 2017 Jan; 23():489-497. PubMed ID: 28128193
[TBL] [Abstract][Full Text] [Related]
67. Prognostic effect of matrix metalloproteinase-9 in patients with resected Non small cell lung cancer.
Lee CY; Shim HS; Lee S; Lee JG; Kim DJ; Chung KY
J Cardiothorac Surg; 2015 Mar; 10():44. PubMed ID: 25888323
[TBL] [Abstract][Full Text] [Related]
68. Expression of tumor necrosis factor receptor-associated factor 6 in lung cancer tissues.
Zhang XL; Dang YW; Li P; Rong MH; Hou XX; Luo DZ; Chen G
Asian Pac J Cancer Prev; 2014; 15(24):10591-6. PubMed ID: 25605144
[TBL] [Abstract][Full Text] [Related]
69. The prognostic significance of ERCC1, BRCA1, XRCC1, and betaIII-tubulin expression in patients with non-small cell lung cancer treated by platinum- and taxane-based neoadjuvant chemotherapy and surgical resection.
Kang CH; Jang BG; Kim DW; Chung DH; Kim YT; Jheon S; Sung SW; Kim JH
Lung Cancer; 2010 Jun; 68(3):478-83. PubMed ID: 19683826
[TBL] [Abstract][Full Text] [Related]
70. Prognostic value of tumor-infiltrating lymphocytes for patients with completely resected stage IIIA(N2) non-small cell lung cancer.
Feng W; Li Y; Shen L; Cai XW; Zhu ZF; Chang JH; Xiang JQ; Zhang YW; Chen HQ; Fu XL
Oncotarget; 2016 Feb; 7(6):7227-40. PubMed ID: 26811495
[TBL] [Abstract][Full Text] [Related]
71. Aberrant Wnt1/β-catenin expression is an independent poor prognostic marker of non-small cell lung cancer after surgery.
Xu X; Sun PL; Li JZ; Jheon S; Lee CT; Chung JH
J Thorac Oncol; 2011 Apr; 6(4):716-24. PubMed ID: 21336184
[TBL] [Abstract][Full Text] [Related]
72. Prognostic value of ERCC1, thymidylate synthase, and glutathione S-transferase pi for 5-FU/oxaliplatin chemotherapy in advanced colorectal cancer.
Kim SH; Kwon HC; Oh SY; Lee DM; Lee S; Lee JH; Roh MS; Kim DC; Park KJ; Choi HJ; Kim HJ
Am J Clin Oncol; 2009 Feb; 32(1):38-43. PubMed ID: 19194123
[TBL] [Abstract][Full Text] [Related]
73. Significance of the presence of microscopic vascular invasion after complete resection of Stage I-II pT1-T2N0 non-small cell lung cancer and its relation with T-Size categories: did the 2009 7th edition of the TNM staging system miss something?
Ruffini E; Asioli S; Filosso PL; Buffoni L; Bruna MC; Mossetti C; Solidoro P; Oliaro A
J Thorac Oncol; 2011 Feb; 6(2):319-26. PubMed ID: 21164365
[TBL] [Abstract][Full Text] [Related]
74. Differential expression of inflammasomes in lung cancer cell lines and tissues.
Kong H; Wang Y; Zeng X; Wang Z; Wang H; Xie W
Tumour Biol; 2015 Sep; 36(10):7501-13. PubMed ID: 25910707
[TBL] [Abstract][Full Text] [Related]
75. Hypoxia-inducible factor-1α and excision repair cross-complementing 1 in patients with small cell lung cancer who received front-line platinum-based chemotherapy: a retrospective study.
Lee GW; Go SI; Cho YJ; Jeong YY; Kim HC; Duk Lee J; Hwang YS; Ko GH; Lee JH; Kim DC; Yang JW; Oh S; Lee JS
J Thorac Oncol; 2012 Mar; 7(3):528-34. PubMed ID: 22258474
[TBL] [Abstract][Full Text] [Related]
76. Subtyping of non-small cell lung carcinoma: a comparison of small biopsy and cytology specimens.
Sigel CS; Moreira AL; Travis WD; Zakowski MF; Thornton RH; Riely GJ; Rekhtman N
J Thorac Oncol; 2011 Nov; 6(11):1849-56. PubMed ID: 21841504
[TBL] [Abstract][Full Text] [Related]
77. Phosphorylated tubulin adaptor protein CRMP-2 as prognostic marker and candidate therapeutic target for NSCLC.
Oliemuller E; Peláez R; Garasa S; Pajares MJ; Agorreta J; Pío R; Montuenga LM; Teijeira A; Llanos S; Rouzaut A
Int J Cancer; 2013 May; 132(9):1986-95. PubMed ID: 23023514
[TBL] [Abstract][Full Text] [Related]
78. Immunohistochemichal expression of biomarkers: a comparative study between diagnostic bronchial biopsies and surgical specimens of non-small-cell lung cancer.
Taillade L; Penault-Llorca F; Boulet T; Fouret P; Michiels S; Taranchon E; Mountzios G; Validire P; Domont J; Girard P; Grunenwald D; Le Chevalier T; Soria JC
Ann Oncol; 2007 Jun; 18(6):1043-50. PubMed ID: 17355950
[TBL] [Abstract][Full Text] [Related]
79. [Clinical significance of ERCC1, RRM1 and TS in non-small cell lung cancer].
Li P; Kang X; Chen K
Zhongguo Fei Ai Za Zhi; 2014 Jun; 17(6):496-500. PubMed ID: 24949692
[No Abstract] [Full Text] [Related]
80. Expression of Bmi1, FoxF1, Nanog, and γ-catenin in relation to hedgehog signaling pathway in human non-small-cell lung cancer.
Gialmanidis IP; Bravou V; Petrou I; Kourea H; Mathioudakis A; Lilis I; Papadaki H
Lung; 2013 Oct; 191(5):511-21. PubMed ID: 23864317
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
